Geo Capital Gestora de Recursos Ltd increased its holdings in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 37.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 12,606 shares of the financial services provider’s stock after purchasing an additional 3,415 shares during the quarter. CME Group accounts for 3.8% of Geo Capital Gestora de Recursos Ltd’s portfolio, making the stock its 12th biggest holding. Geo Capital Gestora de Recursos Ltd’s holdings in CME Group were worth $2,927,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently modified their holdings of CME. Truvestments Capital LLC bought a new position in CME Group in the third quarter valued at about $26,000. SJS Investment Consulting Inc. lifted its holdings in CME Group by 570.6% in the fourth quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 97 shares during the period. Dunhill Financial LLC lifted its holdings in CME Group by 188.4% in the third quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock valued at $27,000 after acquiring an additional 81 shares during the period. Financial Life Planners bought a new position in CME Group in the fourth quarter valued at about $32,000. Finally, Knuff & Co LLC bought a new position in CME Group in the fourth quarter valued at about $33,000. 87.75% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
A number of research firms have weighed in on CME. Citigroup downgraded CME Group from a “buy” rating to a “neutral” rating and lowered their target price for the company from $255.00 to $250.00 in a report on Monday, January 6th. Royal Bank of Canada increased their target price on CME Group from $235.00 to $269.00 and gave the company a “sector perform” rating in a report on Thursday, February 13th. Barclays increased their target price on CME Group from $257.00 to $263.00 and gave the company an “equal weight” rating in a report on Thursday, February 13th. Keefe, Bruyette & Woods upped their price target on CME Group from $256.00 to $257.00 and gave the stock a “market perform” rating in a research report on Friday, February 14th. Finally, Morgan Stanley upped their price target on CME Group from $256.00 to $263.00 and gave the stock an “equal weight” rating in a research report on Wednesday, February 19th. Four investment analysts have rated the stock with a sell rating, eight have issued a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $238.93.
Insider Buying and Selling at CME Group
In other CME Group news, Director Howard J. Siegel sold 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $260.00, for a total transaction of $2,600,000.00. Following the completion of the transaction, the director now owns 21,873 shares in the company, valued at $5,686,980. This trade represents a 31.37 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, COO Suzanne Sprague sold 1,500 shares of the firm’s stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $256.83, for a total value of $385,245.00. Following the transaction, the chief operating officer now owns 8,036 shares of the company’s stock, valued at $2,063,885.88. This represents a 15.73 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 27,076 shares of company stock worth $6,871,496 in the last quarter. 0.30% of the stock is owned by corporate insiders.
CME Group Stock Performance
NASDAQ:CME opened at $263.35 on Friday. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $267.91. The stock has a 50-day moving average price of $246.50 and a 200 day moving average price of $234.07. The stock has a market capitalization of $94.90 billion, a P/E ratio of 27.23, a P/E/G ratio of 6.76 and a beta of 0.53.
CME Group (NASDAQ:CME – Get Free Report) last released its earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%. Equities research analysts forecast that CME Group Inc. will post 10.49 EPS for the current fiscal year.
CME Group Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Friday, March 7th will be issued a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 1.90%. The ex-dividend date of this dividend is Friday, March 7th. This is a boost from CME Group’s previous quarterly dividend of $1.15. CME Group’s dividend payout ratio (DPR) is currently 51.71%.
CME Group announced that its board has initiated a stock repurchase plan on Thursday, December 5th that authorizes the company to repurchase $3.00 billion in shares. This repurchase authorization authorizes the financial services provider to purchase up to 3.4% of its shares through open market purchases. Shares repurchase plans are often a sign that the company’s board of directors believes its shares are undervalued.
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
See Also
- Five stocks we like better than CME Group
- 3 Warren Buffett Stocks to Buy Now
- FedEx Delivers Another Crushing Blow to Its Stock Price
- Stock Analyst Ratings and Canadian Analyst Ratings
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- 3 Best Fintech Stocks for a Portfolio Boost
- Micron Stock Will Retest All-Time Highs This Year
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.